Kidney Cancer
May 6, 2025, 11:41
Diego A Díaz García: ICIs Have Changed the Game in Renal Cell Carcinoma, but Predictive Tools Lag Behind
Diego A Díaz García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology, shared a post on X:
“Biomarkers in renal cell carcinoma: still an unmet need.
ICIs have changed the game in ccRCC, but predictive tools lag behind.
-Why biomarkers successful in other tumor types have fallen short in ccRCC?Emerging predictive and prognostic biomarkers, including gene expression signatures.
Future directions to enable more personalized, biomarker-driven care for patients with kidney cancer.”
Title: Biomarker-informed care for patients with renal cell carcinoma
Journal: Nature Cancer
Authors: Mackenzie B. McKinnon, Brian I. Rini and Scott M. Haake
Read Full Article.
More posts featuring Diego A Díaz García on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 22, 2025, 06:20
Jun 22, 2025, 06:00
Jun 22, 2025, 02:03